- Mitochondria-to-nucleus communication and its role in
breast and other cancers
- Global response to oxidative stress and its role in
breast an other cancers
- Genetics mechanisms of mitochondria-mediated-nuclear
genome instability
- Oxidative damage and its repair in the nucleus and the
mitochondria
With the exception of peripheral red blood
cells, mitochondria are present in all eukaroytic cells in
varying numbers, from hundreds to thousands. Mitochondria
perform multiple cellular function and are the major source of
cellular energy and of reactive oxygen species (ROS). It is
estimated that human cells produce up to 10 million
ROS/mitochondrion/day. In mitochondria, the ROS are formed by
the univalent reduction of molecular oxygen that is mediated by
reactive compounds such as semi-ubiquinone, which are involved
in electron transport chain. ROS cause oxidative stress,
mutations, and promote tumor formation and progression. The
growth promoting effects of oxidative stress in cancer is due to
oxidative stress responsive signal transduction. Oxidative
stress is also implicated in aging, and many diseases including
heart, lung and neurodegenerative diseases.
The long-term goal of our laboratory is to understand the
mechanisms of mitochondria mediated oxidative stress, genomic
instability and its role in cancer. Currently, research in the
laboratory is focused on identifying pathway(s) that protect
cells from mitochondrial oxidative stress and genomic
instability of both the mitochondrial and nuclear genomes. We
are also conducting experiments to identify genes that are
involved in monitoring the functional state of mitochondria
and transducing signals from dysfunctional mitochondria to the
nucleus (Mitochondria-to-Nucleus communication). These studies
employ the unicellular eukaryote Saccharomyces cerevisiae
yeast, mouse, and mammalian cell culture model systems to
study these processes. Environmental carcinogens,
pharmacological and chemotherapeutic agents are used to induce
oxidative stress and genomic instability. Our approach uses
both molecular and genetic methods in concert: molecular
assays are used to detect and characterize genes of interest
and in vivo function of the proteins is assessed by genetic
analysis. In addition to understanding basic mechanisms, we
have taken a multidisciplinary translational approach to
identify molecular markers of oxidative stress involved in
detection, diagnosis and treatment of cancer and other
oxidative stress related diseases. Described below
are the ongoing projects in my laboratory |